three people smiling reading

Leadership Team

Founders & Advisors Darin Rubin, MBA, MPH, Bedrick Gadea, PhD, and Robert Hung, M.Eng. created The Dedham Group in 2010 with a highly specific vision: unrelenting commitment to excellence in partnership, deep subject matter expertise, and unparalleled precision, insights and strategic guidance. The leadership team propels this vision forward with the support of an impressive, diverse team of critical thinkers with a collective array of specialized experience spanning decades.

Aaron McKeon-Fish

Aaron McKeon-Fish, MBA

Aaron McKeon-Fish has over 15 years of experience within biotechnology and life science industry, serving as a thought partner and support strategy development for life sciences organizations across a breadth of therapeutic areas, including oncology, immunology, neurology, cardiology & rare disease. Areas of expertise include pricing & contracting, channel economics, launch excellence playbooks, loss of exclusivity/biosimilar channel targeting & positioning. His deep expertise in competitive scenario planning has supported many clients’ GTM strategies aligned to optimizing patient access.

Aaron holds a B.S. in biochemistry from The College of New Jersey, and an M.B.A (strategy, management) from New York University Stern School of Business. Prior to joining TDG, Aaron worked in life sciences strategy consulting at McCann Health and in early stage oncology/ hematology drug discovery at The Children’s Hospital of Philadelphia.

sophia tan

Sophia Tan, PhD

Sophia Tan has over 15 years of experience in the biotechnology and life sciences industry, specialized in market access and commercial strategy with in-depth expertise in clinical pathways, value-based care, and precision medicine. She has been a thought partner for numerous biopharma clients, providing strategic advice on a wide array of issues including clinical pathway strategy and operational planning, payer and provider channel engagement, go-to-market strategy, and value-based care.

Prior to joining TDG, Sophia received her doctoral degree and led clinical research on neural stem cells at Weill Cornell and Memorial Sloan-Kettering. Her research has been presented at international conferences and published in top peer-reviewed journals.

jen klarer

Jen Klarer, M.Sc.Eng.

Jen Klarer has over a decade of experience in multi-channel market analysis and strategic access optimization, spanning specialty therapeutic categories including cell and gene therapy, oncology, immunology, and rare disease. Areas of differentiated expertise include coverage and reimbursement modeling, provider site activation planning and commercial operations configuration (distribution, patient services, and field team execution) to optimize patient reach.

Jen has a Bachelor of Arts in chemistry from Franklin & Marshall College and a Master of Science in biomedical engineering from Columbia University. Prior to joining TDG, she conducted six years of academic research, including pre-clinical study of an autologous cell therapy for critical limb ischemia.

James Pisano

James Pisano

James Pisano has extensive experience across specialty therapeutic classes including immunology, neuroscience, ultra-rare disease, and women’s health. Areas of particular focus include economic modeling, deconstructing evolution in stakeholder business models, and mapping influence across customers.

James studied biomedical engineering & economics, earning a bachelor’s degree from Northwestern University. During his time at Northwestern, he conducted research on the physiological implications of ischemic stroke.

Matthew Cunningham

Matthew Cunningham

Matthew Cunningham has broad experience in oncology provider model evolution, precision medicine & population health strategies. Matt has supported provider channel engagement strategies for dozens of oncology brands and continues to work with many clients in the development of key account / field team infrastructure and targeting strategies.

Matt studied healthcare management & policy, earning his bachelor’s degree from Georgetown University, and has administrative experience at both an NCI-accredited cancer center and a community oncology practice.

david sauchelli

David Sauchelli

VP, Business Operations
As Dedham’s VP, Business Operations, Dave Sauchelli is responsible for overseeing the firm’s finance and business operations functions, including FP&A, human resources, contracting, and systems integrations/implementations.

Dave joined Dedham in 2013 and works to develop strategic business and accelerated growth plans alongside the partners.

With over 15 years of professional experience, he began his career at Prudential Financial helping individuals and institutions improve their financial wellness. Dave studied finance, earning his bachelor’s degree from New Jersey City University.